Invive

We’re applying the radical new science of epigenetics to the insurance industry.

  • Stage Product In Market
  • Industry Insurtech
  • Location Minneapolis, MN, USA
  • Currency USD
  • Founded April 2022
  • Employees 2
  • Incorporation Type C-corp
  • Website invive.io

Company Summary

Invive leverages the science of epigenetics to assess your health risk for under $100, using an at-home saliva test. Using patented technology, Invive can detect different kinds of smoking in the past year, alcohol abuse in the past 3 months, and other high-value health risk markers. Eliminating the need for needles and paramed visits, we’re looking to disrupt how risk is quantified in the $1 trillion life insurance industry.

Team

  • Diego Tanton
    Co-founder & CEO

    After studying molecular biology and entrepreneurship at Johns Hopkins, I worked at the National Institute on Aging and then in the life insurance space.

  • Ahnaf Prio
    Co-founder & CTO

    Ahnaf is a repeat CTO who has worked as a software engineer at large companies like Securian Financial and Best Buy.

  • Robert Philibert
    CMO

    Rob is the inventor of our technology and a world-renowned expert in epigenetics. He’s also the inventor of the technology powering Cardio Diagnostics, which is now listed on the NASDAQ.

  • Kelsey Dawes
    CSO

    Kelsey is an expert in the epigenetics field who has experience running a research lab at a high scale. She is also the inventor of our technology and knows the intricacies of our tests.

Advisors

Previous Investors

  • Global Insurance Accelerator
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free